Hepatic artery resistance as a marker for preservation/reperfusion injury.
Eisele
R M
RM
Department of General, Visceral, and Transplantation Surgery, Charité Campus Virchow-Klinikum, Medizinische Fakultät der Humboldt-Universität zu Berlin, Berlin, Germany. rmeisele@charite.de
Meissner
W
W
Nüssler
N C
NC
Platz
K P
KP
Settmacher
U
U
Neuhaus
P
P
D000241:Adenosine / Q000494:pharmacology; D000493:Allopurinol / Q000494:pharmacology; D000818:Animals; D005260:Female; D005978:Glutathione / Q000494:pharmacology; D006499:Hepatic Artery / Q000187:drug effects / Q000502:physiology*; D007328:Insulin / Q000494:pharmacology; D008099:Liver / Q000098:blood supply*; D009926:Organ Preservation / Q000009:adverse effects*; D019188:Organ Preservation Solutions / Q000494:pharmacology; D011887:Raffinose / Q000494:pharmacology; D015424:Reperfusion / Q000379:methods; D015427:Reperfusion Injury / Q000503:physiopathology*; D013552:Swine; D014655:Vascular Resistance / Q000187:drug effects / Q000502:physiology*
D007328:Insulin; D019188:Organ Preservation Solutions; C055206:University of Wisconsin-lactobionate solution; D000493:Allopurinol; D005978:Glutathione; D000241:Adenosine; D011887:Raffinose